Our Research

Our Preclinical Drug Development Research

Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

Characterization of a Mouse Model of Parkinson’s Disease

Characterization of a Rat Model of Thoracic Spinal Cord Injury

Characterization of a Mouse Model of CMT2E

Characterization of a Rat Model of CMT2A

Characterization of the Ube3a Mouse Model of Angelman Syndrome

Characterization of a Mouse and Rat Model of CMT1A

Overcoming mental health’s drug development challenges with AI

PsychoGenics – Phenotypic Drug Discovery and Preclinical CRO

We need a new Prozac: The demand for new brain drug innovation

Mental Health Champions: Why & How Dr. Emer Leahy of PsychoGenics Is Helping To Champion Mental Wellness

The CNS drug development drum beat is getting louder

Emyria starts program with neuroscience drug discovery CRO

{{ x.card_name }}

{{ x.title }}

There are no resources to display.

Partner with us and transform your program

DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS

Get Started